In recent years, the role of ILC2 in the pathogenesis of T2 asthma has been clarified with evidence of the triggering effect of thymic stromal lymphopoietin (TSLP) and IL-33, which have been correlated with more severe asthma, as well as glucocorticoid resistance [10]. The gene discussed is IL33; the disease is asthma.